We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
The National Health and Medical Research Council (NHMRC) has established the Vitamin B6 Expert Working Group to support the review and update of the vitamin B6 upper level of intake (UL) for Australia and New Zealand (NRVs).
This work forms part of an ongoing review of priority NRVs, overseen by the Steering Group comprising representatives from NHMRC, the Australian Government Department of Health, Disability and Aged Care, and the New Zealand Ministry of Health.
Members of the Vitamin B6 Expert Working Group were selected to ensure appropriate expertise in the specific nutrient, general nutrition and dietetics, nutrient deficiency and toxicity, statistics and modelling, systematic reviews, monitoring nutritional status and setting and implementing NRVs.
For further information see Committees advising on the review of Nutrient Reference Values.
The Vitamin B6 Expert Working Group will provide expert advice on the review and update of the Upper Level (UL) for Vitamin B6. This review forms part of NHMRC’s rolling review of priority Nutrient Reference Values (NRVs) for Australia and New Zealand, overseen by a Steering Group comprising representatives from the NHMRC, Australian Government Department of Health, Disability and Ageing and New Zealand Ministry of Health.
The Vitamin B6 Expert Working Group will:
The Vitamin B6 Expert Working Group will report to the Steering Group.
Appointments to the Vitamin B6 Expert Working Group will conclude on 28 February 2027.
NHMRC asks all committee members to document their interests for consideration by a CEO delegate prior to being appointed to the committee. Members are asked to update their interests during the term of their appointment or as soon as practicable after becoming aware of the interest or that there has been a change in the nature or extent of the interest. Members are asked to consider perceived interests as well as actual interests. A summary of the interests declared by each member is provided within the declarations (below).
(Commenced March 2026 to present)
Professor at Flinders University
Relevant experience:
(Commenced March 2026 to present)
Senior Research Fellow with Health Evidence Synthesis Recommendations and Impact (HESRI) at Adelaide University
Relevant experience:
(Commenced March 2026 to present)
Associate Professor with the Sydney Pharmacy School at University of Sydney
Relevant experience:
(Commenced March 2026 to present)
Senior Toxicologist with Food Standards Australia New Zealand
Relevant experience:
(Commenced March 2026 to present)
Chemical Pathologist with Sullivan Nicolaides Pathology
Relevant experience:
(Commenced March 2026 to present)
Professor of Population Nutrition at University of Auckland
Relevant experience:
(Commenced March 2026 to present)
Associate Professor (Complementary Medicines) at University of Sydney
Relevant experience:
(Commenced March 2026 to present)
Head of Clinical Neurophysiology at Alfred Health
Relevant experience:
(Commenced March 2026 to present)
Senior Staff Specialist at Royal Prince Alfred Hospital
Relevant experience:
(Commenced March 2026 to present)
Senior Research Fellow for JBI at Adelaide University
Relevant experience:
(Commenced March 2026 to present)
Chair of Public Health at Australian Medical Association
Relevant experience:
(Commenced March 2026 to present)
APJ Region Counsel, aaS and High-Performance Compute; Senior Legal Counsel, South Pacific at Hewlett Packard Enterprise
Relevant experience: